Global Cardiac Pacemakers Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global cardiac pacemakers market in its upcoming report titled, “Global Cardiac Pacemakers Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global cardiac pacemakers market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global cardiac pacemakers market report has been segmented on the basis of product, technology, end user, and region.

Request Covid - 19 Impact

Cardiac pacemaker is a small device that delivers an electric current to heart which helps in maintaining proper control over heartbeats. Cardiac pacemakers can be implantable or external or can be biventricular, single-chambered, or dual-chambered. Implantable pacemakers are extensively used over the external pacemakers.

High prevalence rate coupled with increasing incidence of cardiovascular disease across the globe is a major factor driving growth of the global cardiac pacemakers market. In addition, developments in pacemakers especially, in material and software used for cardiac pacemakers, and increasing number of government initiatives for spreading awareness about cardiovascular diseases and treatments are some other factors expected to propel growth of the global cardiac pacemakers market over the forecast period.

However, high costs associated with treatment is major factor restraining growth of the global cardiac pacemakers market. Additionally, increasing number of product recalls owing to improper functioning and other issues is another factor expected to hamper growth of the global cardiac pacemakers market over the forecast period.

Major and growing trend in the market is increasing use of dual-chamber pacemakers and development of implantable cardioverter defibrillator and leadless pacemaker devices, which are expected to fuel growth of the global market over the forecast period.

The market in North America is expected to account for highest share in terms of revenue and is expected to maintain its dominance over the forecast period. This dominance can be attributed to increasing adoption of cardiac pacemakers due to increasing incidence of diabetes, obesity, and hypertension among individuals in countries in the region. The market in the Europe is expected to account for second-highest share in terms of revenue, owing to well-developed healthcare facilities and increasing government support for research & development of cardiac pacemakers in the region. Also, the market in Asia Pacific is expected to register significant growth in the target market over the forecast period, owing to increasing incidence of cardiovascular diseases in emerging economies such as China, Japan, and India.

Global cardiac pacemakers market segmentation:

By Product:

• External cardiac pacemaker
• Implantable cardiac pacemaker

By Technology:

• Biventricular
• Single chambered
• Dual chambered

By End user:

• Clinics and Hospitals
• Ambulatory Surgical Centers
• Cardiac Care Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• Lepu Medical Technology (Beijing) Co., Ltd.
• LivaNova PLC
• Medica S.p.A.
• Oscor, Inc.
• Osypka Medical GmbH
• Uscom Limited